# K930865: Staodyn Maxima Iii

- Pathway: 510(k) (Traditional)
- Applicant: Staodyne, Inc.
- Decided: May 13, 1993 after 84 days
- Product code: GZJ (Stimulator, Nerve, Transcutaneous, For Pain Relief)
- Device class: 2
- Regulation: 21 CFR 882.5890
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
6 later devices descend from it; 1 cites it directly.
0 of 7 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

## Most influential descendants
- K022405: Modification to Promax-XP, Tens and Microcurrent Device; Promax-Tens, Tens Device; Promax-Libra, Tens Device; Promax-Mic (2002), 5 descendants of its own
- K081835: Acticare IC and Tse (2009), 3 descendants of its own
- K161091: STIMPOD NMS460 Nerve Stimulator (2017), 2 descendants of its own
- K252712: STIMPOD NMS460 Nerve Stimulator (2026), 0 descendants of its own
- K213802: StimOnTM Pain Relief System (GM2439) (2022), 0 descendants of its own

Source page: https://510kreport.com/device/K930865
Methodology: https://510kreport.com/methodology